The calendar may have flipped to April, but trade drama is still driving the markets. President Trump’s April 2 “Liberation ...

The Goldman Sachs Group upgraded shares of AutoZone (NYSE:AZO – Free Report) from a sell rating to a neutral rating in a ...

Goldman Sachs downgraded Genuine Parts Co (NYSE:GPC) to "Sell" from "Neutral" while upgraded AutoZone Inc (NYSE:AZO) to "Neutral" from "Sell" citing differing levels of cyclicality and defensive ...

Goldman Sachs downgrades Genuine Parts to "Sell" due to market challenges, while upgrading AutoZone to "Neutral" amid ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Goldman Sachs weighed in on the auto retailer sector on Tuesday amid the ongoing volatility in the broad market and the increased concern around slowing consumer activity and economic uncertainty. The ...

Fintel reports that on April 1, 2025, Goldman Sachs upgraded their outlook for AutoZone (NYSE:AZO) from Sell to Neutral.

Goldman Sachs analyst Kate McShane upgraded AutoZone (AZO) to Neutral from Sell with a price target of $3,811, up from $3,044. The firm cites ...

Also, AutoZone (AZO) is up more than +1% ... Phillips 66 (PSX) is down more than -1% after Goldman Sachs downgraded the stock to neutral from buy. Soleno Therapeutics (SLNO) is up more than +36% after ...

Shares of Adaptive Biotechnologies (NASDAQ:ADPT) climbed in the morning hours on Friday after Goldman Sachs upgraded the stock to Buy from Neutral, arguing that the cancer test maker operates in ...

Goldman Sachs analyst James Quigley upgraded Sanofi (SNYNF – Research Report) to a Hold today and set a price target of €120.00. The company’s shares closed last Wednesday at $119.06.

Goldman Sachs BDC cut its base dividend by 29% due to high non-accruals and decreased net investment income, impacting income-dependent investors. Despite the dividend cut, GSBD remains attractive ...